title: Management of gonococcal infection among adults and youth: New key recommendations.
abstract: OBJECTIVE
  To provide recommendations on the management of gonococcal infection among adults and youth.
  
  
  METHODS
  Treatment recommendations in the Canadian guidelines on sexually transmitted infections are based on review of the literature, as well as the grades of recommendations and the levels of evidence quality determined by a minimum of 2 reviewers. The recommendations are peer-reviewed and require approval by the expert working group.
  
  
  RESULTS
  The new key recommendations for managing gonococcal infection among adults and youth include using culture as a diagnostic tool when practical, providing treatment with combination antibiotic therapy (ceftriaxone combined with azithromycin), and promptly reporting all cases with treatment failure to public health.
  
  
  CONCLUSIONS
  Following these new key recommendations might reduce treatment failure, contribute to better surveillance of antibiotic-resistance trends in Neisseria gonorrhoeae, and contribute to the prevention of transmission of multidrug-resistant gonorrhea.
authors.affiliation: Epidemiologist in the Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada in Ottawa, Ont. lisa.pogany@phac-aspc.gc.ca.
authors.forename: Lisa
authors.initials: L
authors.lastname: Pogany
authors.affiliation: Clinical Professor of Medicine in the Faculty of Medicine and Dentistry at the University of Alberta in Edmonton.
authors.forename: Barbara
authors.initials: B
authors.lastname: Romanowski
authors.affiliation: Pediatric infectious diseases physician at the University of Alberta and the Stollery Children's Hospital in Edmonton.
authors.forename: Joan
authors.initials: J
authors.lastname: Robinson
authors.affiliation: Acting Director, Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada.
authors.forename: Margaret
authors.initials: M
authors.lastname: Gale-Rowe
authors.affiliation: Nurse consultant, Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada.
authors.forename: Cathy
authors.initials: C
authors.lastname: Latham-Carmanico
authors.affiliation: Nurse epidemiologist, Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada.
authors.forename: Christine
authors.initials: C
authors.lastname: Weir
authors.affiliation: Past Director of the Professional Guidelines and Public Health Practice Division, Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada.
authors.forename: Tom
authors.initials: T
authors.lastname: Wong
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D002170:Canada; D002443:Ceftriaxone / Q000627:therapeutic use*; D019468:Disease Management; D004359:Drug Therapy, Combination; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D009344:Neisseria gonorrhoeae; D017410:Practice Guidelines as Topic
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D017963:Azithromycin